<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(7)</volume><submitter>Pisano ECL</submitter><funding>Biotronik SE &amp;amp; Co KG</funding><funding>Biotronik SE &amp; Co KG</funding><pubmed_abstract>&lt;h4>Aims&lt;/h4>Subclinical atrial fibrillation (AF) is associated with increased risk of progression to clinical AF, stroke, and cardiovascular death. We hypothesized that in pacemaker patients requiring dual-chamber rate-adaptive (DDDR) pacing, closed loop stimulation (CLS) integrated into the circulatory control system through intra-cardiac impedance monitoring would reduce the occurrence of atrial high-rate episodes (AHREs) compared with conventional DDDR pacing.&lt;h4>Methods and results&lt;/h4>Patients with sinus node dysfunctions (SNDs) and an implanted pacemaker or defibrillator were randomly allocated to dual-chamber CLS (n = 612) or accelerometer-based DDDR pacing (n = 598) and followed for 3 years. The primary endpoint was time to the composite endpoint of the first AHRE lasting ≥6 min, </pubmed_abstract><journal>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</journal><pagination>euae175</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11226787</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Closed loop stimulation reduces the incidence of atrial high-rate episodes compared with conventional rate-adaptive pacing in patients with sinus node dysfunctions.</pubmed_title><pmcid>PMC11226787</pmcid><pubmed_authors>Coppolino A</pubmed_authors><pubmed_authors>Merkely B</pubmed_authors><pubmed_authors>Menichelli M</pubmed_authors><pubmed_authors>Ching CK</pubmed_authors><pubmed_authors>Botto GL</pubmed_authors><pubmed_authors>Carretta DM</pubmed_authors><pubmed_authors>Arena G</pubmed_authors><pubmed_authors>Pelargonio G</pubmed_authors><pubmed_authors>Gargaro A</pubmed_authors><pubmed_authors>Saporito D</pubmed_authors><pubmed_authors>Del Maestro M</pubmed_authors><pubmed_authors>Lazzari L</pubmed_authors><pubmed_authors>Su X</pubmed_authors><pubmed_authors>Rapacciuolo A</pubmed_authors><pubmed_authors>Del Castillo AM</pubmed_authors><pubmed_authors>Calvi V</pubmed_authors><pubmed_authors>Nicosia A</pubmed_authors><pubmed_authors>Bertaglia E</pubmed_authors><pubmed_authors>Viscusi M</pubmed_authors><pubmed_authors>Caccavo V</pubmed_authors><pubmed_authors>Lin LY</pubmed_authors><pubmed_authors>Giacopelli D</pubmed_authors><pubmed_authors>Wang CC</pubmed_authors><pubmed_authors>Bontempi L</pubmed_authors><pubmed_authors>Oh IY</pubmed_authors><pubmed_authors>Pisano ECL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Closed loop stimulation reduces the incidence of atrial high-rate episodes compared with conventional rate-adaptive pacing in patients with sinus node dysfunctions.</name><description>&lt;h4>Aims&lt;/h4>Subclinical atrial fibrillation (AF) is associated with increased risk of progression to clinical AF, stroke, and cardiovascular death. We hypothesized that in pacemaker patients requiring dual-chamber rate-adaptive (DDDR) pacing, closed loop stimulation (CLS) integrated into the circulatory control system through intra-cardiac impedance monitoring would reduce the occurrence of atrial high-rate episodes (AHREs) compared with conventional DDDR pacing.&lt;h4>Methods and results&lt;/h4>Patients with sinus node dysfunctions (SNDs) and an implanted pacemaker or defibrillator were randomly allocated to dual-chamber CLS (n = 612) or accelerometer-based DDDR pacing (n = 598) and followed for 3 years. The primary endpoint was time to the composite endpoint of the first AHRE lasting ≥6 min, </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-02T22:49:20.611Z</modification><creation>2025-04-04T12:21:57.031Z</creation></dates><accession>S-EPMC11226787</accession><cross_references><pubmed>38938169</pubmed><doi>10.1093/europace/euae175</doi></cross_references></HashMap>